Retrophin, Inc. has announced the closing of the agreement to sell its Rare Pediatric Disease Priority Review Voucher to Sanofi Under the terms of the agreement, Retrophin has received a payment of $150 million, and will receive two additional payments of $47.5 million in 2016 and 2017. Retrophin also announced the prepayment of its $45 million […]
News: Retrophin sold Priority Review Voucher to Sanofi $RTRX Read More »
Materialise NV , a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced the appointment of Johan Albrecht as chief financial officer effective August 12, 2015. Mr. Albrecht, age 52, joins Materialise from BARC NV, a global central laboratory that supports the pharmaceutical and biotech industry in the development of
News: New CFO at Materialise $MTLS Read More »
iRobot Corporation, A Robot making firm for the needs of any Home of Business purpose, has announced that resignation of its Chief Technology Officer (CTO) Paolo Pirjanian. The resignation will be effective from October 2015. No further replacement is yet announced. View the full release here.
News: iRobot CTO Resigns $IRBT Read More »
Abbott Inc., has announced that it will announce its second quarter results for FY-2015-16, on May 22nd 2015. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern), and will be accessible through Abbott’s Investor Relations website at www.abbottinvestor.com. An archived edition of
News: Abbott Earnings Call for Financials $ABT Read More »
Synergy Pharmaceuticals Inc.has announced that it has appointed Timothy Callahan and Richard Daly as new independent directors to its board. Both Mr. Callahan and Mr. Daly have direct experience in primary care and gastrointestinal markets and have led large organizational change and successful business growth, in a variety of areas, including all aspects of commercial, acquisitions,
News: Synergy Adds Professionals to BOD $SGYP Read More »
